GreenLight Biosciences Holdings

GRNA · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$167-$112-$53-$29
Dep. & Amort.$8$6$2$1
Deferred Tax$0$1$0-$0
Stock-Based Comp.$9$2$1$0
Change in WC$8$11$4$2
Other Non-Cash$5$1$1$0
Operating Cash Flow-$137-$92-$47-$26
Investing Activities
PP&E Inv.-$27-$15-$10-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$27-$15-$10-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$106$207$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$201$44$126$13
Financing Cash Flow$201$44$126$13
Forex Effect$0$0$0$0
Net Chg. in Cash$38-$63$69-$14
Supplemental Information
Beg. Cash$32$95$26$40
End Cash$69$32$95$26
Free Cash Flow-$163-$107-$57-$28
GreenLight Biosciences Holdings (GRNA) Financial Statements & Key Stats | AlphaPilot